Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Erica B Flores"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Oncolytic therapy uses live-replicating viruses to improve the immunological status of treated tumors. Critically, while these viruses are known to self-amplify in vivo, clinical oncolytic therapies still appear to display a strong dose de
Externí odkaz:
https://doaj.org/article/a1aea64f6a5b43d3aa4ef2b090bdf109
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231977 (2020)
Poxviruses are large enveloped viruses that replicate exclusively in the cytoplasm. Like all viruses, their replication cycle begins with virion adsorption to the cell surface. Unlike most other viral families, however, no unique poxviral receptor ha
Externí odkaz:
https://doaj.org/article/53359f803a224f28ac6ef0ade80a33a8
Autor:
Erik N. Taylor, Colin M. Wilson, Stefan Franco, Henning De May, Lorél Y. Medina, Yirong Yang, Erica B. Flores, Eric Bartee, Reed G. Selwyn, Rita E. Serda
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 18; Pages: 10525
Current imaging approaches used to monitor tumor progression can lack the ability to distinguish true progression from pseudoprogression. Simultaneous metabolic 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) positron emission tomography (PET) and magneti
Autor:
Eric Bartee, Erica B Flores
Publikováno v:
Molecular Therapy: Oncolytics, Vol 19, Iss, Pp 323-331 (2020)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Oncolytic virotherapy relies on the induction of anti-tumor immune responses to achieve therapeutic efficacy. The factors that influence the induction of these responses, however, are not well understood. To begin to address this lack of knowledge, w
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231977 (2020)
PLoS ONE
PLoS ONE
Poxviruses are large enveloped viruses that replicate exclusively in the cytoplasm. Like all viruses, their replication cycle begins with virion adsorption to the cell surface. Unlike most other viral families, however, no unique poxviral receptor ha
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundOncolytic therapy uses live-replicating viruses to improve the immunological status of treated tumors. Critically, while these viruses are known to self-amplify in vivo, clinical oncolytic therapies still appear to display a strong dose dep
Autor:
Erica B. Flores, Eric Bartee
Publikováno v:
Molecular Therapy: Oncolytics, Vol 19, Iss , Pp 323-331 (2020)
Oncolytic virotherapy relies on the induction of anti-tumor immune responses to achieve therapeutic efficacy. The factors that influence the induction of these responses, however, are not well understood. To begin to address this lack of knowledge, w
Externí odkaz:
https://doaj.org/article/e31c244cb78d4cca803dac13b0726680